Polymorphisms in SLCO1B3 and NR1I2 as genetic determinants of hematotoxicity of carboplatin and paclitaxel combination

被引：0
|
作者：
Mbatchi, Litaty Cephanoee [1 ,2 ,3 ]
Schmitt, Antonin [4 ,5 ]
Thomas, Fabienne [4 ,5 ]
Cazaubon, Yoann [3 ]
Robert, Jacques [6 ]
Lumbroso, Serge [1 ]
Brouillet, Jean-Paul [1 ,2 ]
Pourquier, Philippe [2 ]
Chatelut, Etienne [4 ,5 ]
Boyer, Jean-Christophe [1 ]
Evrard, Alexandre [1 ,2 ,3 ]
机构：
[1] Ctr Hosp Univ Nimes, Hop Caremeau, Biochim Lab, Nimes, France
[2] INSERM, U1194, Inst Rech Cancerol Montpellier, F-34298 Montpellier, France
[3] Univ Montpellier, Fac Pharm, Lab Pharmacocinet, F-34059 Montpellier, France
[4] Inst Claudius Regaud, EA4553, Toulouse, France
[5] Univ Toulouse 3, F-31062 Toulouse, France
[6] Univ Bordeaux, Inst Bergonie, INSERM U916, Bordeaux, France
来源：
PHARMACOGENOMICS | 2015年 / 16卷 / 13期
关键词：
carboplatin; drug metabolism; hematotoxicity; paclitaxel; pregnane X-receptor; PXR; SLCO1B3; SNP; PREGNANE-X-RECEPTOR; CELL LUNG-CANCER; OVARIAN-CANCER; MELTING ANALYSIS; PHASE-I; PHARMACOKINETICS; CHEMOTHERAPY; ASSOCIATION; TOXICITY; PHARMACOGENETICS;
D O I：
10.2217/PGS.15.84
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Aim: The goal of our study was to assess the impact of patients' genetic background on their sensitivity to carboplatin/paclitaxel hematotoxicity. Patients & methods: Parameters describing sensitivity to neutropenia and to thrombocytopenia of 201 patients were extracted from a previous pharmacokinetic/pharmacodynamics analysis, in order to assess their association with 52 candidates SNPs in 18 genes. Results: Carriers of a T allele of SLCO1B3-rs4149117 were 19% less sensitive to thrombocytopenia than the homozygotes for the G allele (p = 0.00279). Carriers of two copies of the ATG haplotypes of NR1I2-rs1523130, rs3814055 and rs1523127 were 19% less sensitive to thrombocytopenia than those harboringother haplotypes (p = 0.025). Conclusion: Our results revealed the importance of SLCO1B3 and NR1I2 in the sensitivity to carboplatin/paclitaxel thrombocytopenia.
引用
收藏
页码：1439 / 1450
页数：12
相关论文
共 50 条
  • [21] Influence of Genomic Ancestry on the Distribution of SLCO1B1, SLCO1B3 and ABCB1 Gene Polymorphisms among Brazilians
    Sortica, Vinicius de A.
    Ojopi, Elida B.
    Genro, Julia P.
    Callegari-Jacques, Sidia
    Ribeiro-dos-Santos, Andrea
    de Moraes, Manoel Odorico
    Romano-Silva, Marco A.
    Pena, Sergio D. J.
    Suarez-Kurtz, Guilherme
    Hutz, Mara H.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2012, 110 (05) : 460 - 468
  • [22] Identification of NR1I2 genetic variation using resequencing
    Cristi R. King
    Ming Xiao
    Jinsheng Yu
    Matthew R. Minton
    Nicholas J. Addleman
    Derek J. Van Booven
    Pui-Yan Kwok
    Howard L. McLeod
    Sharon Marsh
    European Journal of Clinical Pharmacology, 2007, 63 : 547 - 554
  • [23] Association of NR1I2 gene polymorphisms and time of progression to AIDS
    de Medeiros, Rubia Marilia
    Menti, Carolina Fialho
    Benelli, Jessica Louise
    Cotta Matte, Maria Cristina
    de Melo, Marineide Goncalves
    de Matos Almeida, Sabrina Esteves
    Fiegenbaum, Marilu
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2017, 112 (04): : 269 - 274
  • [24] THE INFLUENCE OF SLCO1B3 POLYMORPHISMS ON DOCETAXEL DISPOSITION IN ASIAN NASOPHARYNGEAL CARCINOMA PATIENTS
    Chew, S.
    Mann, O.
    Ramasamy, R.
    Lim, W.
    Tan, E.
    Lee, E. J.
    Chowbay, B.
    ANNALS OF ONCOLOGY, 2010, 21 : 52 - 52
  • [25] PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population
    Lima, Luciana O.
    Almeida, Silvana
    Hutz, Mara H.
    Fiegenbaum, Marilu
    MOLECULAR BIOLOGY REPORTS, 2013, 40 (02) : 1241 - 1247
  • [26] PPARA, RXRA, NR1I2 and NR1I3 gene polymorphisms and lipid and lipoprotein levels in a Southern Brazilian population
    Luciana O. Lima
    Silvana Almeida
    Mara H. Hutz
    Marilu Fiegenbaum
    Molecular Biology Reports, 2013, 40 : 1241 - 1247
  • [27] Effects of NR1I2 and ABCB1 Genetic Polymorphisms on Everolimus Pharmacokinetics in Japanese Renal Transplant Patients
    Yagishita, Hironobu
    Kagaya, Hideaki
    Saito, Mitsuru
    Numakura, Kazuyuki
    Yamamoto, Ryohei
    Sagehashi, Ryuichiro
    Habuchi, Tomonori
    Satoh, Shigeru
    Miura, Masatomo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [28] SLCO1B3 polymorphisms and clinical outcomes in kidney transplant recipients receiving mycophenolate
    Schumacher, Lauren
    Fang, Fang
    Kidwell, Kelley M.
    Shakeel, Faisal
    Hertz, Daniel L.
    Park, Jeong M.
    Pasternak, Amy L.
    PHARMACOGENOMICS, 2021, 22 (17) : 1111 - 1120
  • [29] Ethnic Differences in the Frequency of Polymorphisms in Influx Transporters SLC10A1, SLC22A1, SLCO1B3, and SLCO1B1
    Dias, Vera
    Ribeiro, Vera
    DRUG METABOLISM REVIEWS, 2009, 41 : 77 - 77
  • [30] COMBINATION OF SLCO1B3 AND SLCO2B1 POLYMORPHISM CAN PREDICT THE DURATION OF THE RESPONSE TO ANDROGEN DEPRIVATION THERAPY IN ADVANCED PROSTATE CANCER
    Fujimoto, Naohiro
    Kubo, Tatsuhiko
    Bui, Hoai
    Yoshida, Takeshi
    Inatomi, Hisato
    Matsumoto, Tetsuro
    JOURNAL OF UROLOGY, 2012, 187 (04): : E195 - E196
12345